Opendata, web and dolomites


Mechanism of allosteric regulation of SHP2 phosphatase and its role in cancer and geneticdiseases: a multidisciplinary computational, structural and biological approach

Total Cost €


EC-Contrib. €






 MARS project word cloud

Explore the words cloud of the MARS project. It provides you a very rough idea of what is the project "MARS" about.

tumors    peptidomimetic    ray    inhibit    mutations    found    30    inhibitors    expertise    structure    50    perturb    regulation    treat    dissociation    causes    somatic    basal    functional    compatible    deeper    germline    protein    encoding    site    combined    dynamics    coupled    compounds    dysregulation    assays    noonan    jmml    dynamic    molecules    malignancies    mapk    biology    binding    allosteric    goals    mechanism    er    xs    mechanisms    phosphopeptide    specialist    researcher    shp2    juvenile    activation    transition    hematologic    src    external    shows    syndrome    tyrosine    atomic    ptpn11    myelomonocytic    domains    of    ligand    italian    hi    regulatory    complemented    molecular    sh2    expert    blocks    domain    diseases    whereas    multidomain    scattering    inactive    signaling    host    human    containing    disease    terminal    function    biochemical    rarely    ras    architecture    ptp    consolidated    favoring    gene    homology    active    guaranteed    combination    leukemia    implicated    md    events    dissect    phosphatase    class    computational    pp    individuals   

Project "MARS" data sheet

The following table provides information about the project.


Organization address
postcode: 37073

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 159˙460 €
 EC max contribution 159˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-04-01   to  2019-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

SHP2 is an SH2 domain-containing protein tyrosine phosphatase with a key role in the RAS-MAPK signaling pathway. Germline mutations in PTPN11, the gene encoding SHP2, occur in 50% of individuals affected by Noonan syndrome, whereas somatic mutations in this gene cause more than 30% of cases of juvenile myelomonocytic leukemia (JMML), and are more rarely found in other hematologic malignancies and tumors. The X-ray structure of SHP2 shows a multidomain architecture compatible with an allosteric regulatory mechanism: under basal conditions SHP2 is inactive, because its N-terminal Src homology 2 (N-SH2) domain blocks the active site of the protein tyrosine phosphatase (PTP) domain. Binding of the N-SH2 domain to a phosphopeptide (PP) ligand causes SHP2 activation by favoring dissociation of the N-SH2 and PTP domains. To characterize this dynamic transition at the atomic level, will be used a combination of state of the art computational methods coupled to X-ray scattering (XS) and biochemical assays. Major goals of the proposed studies are to explain how disease-associated mutations perturb the regulatory events controlling SHP2 function, and design new molecules able to inhibit SHP2 binding to signaling partners. The project implementation is guaranteed by the expertise of the Experienced Researcher (ER) in molecular dynamics (MD) studies of allosteric mechanisms that is complemented by the consolidated expertise of the host institution (HI) in the combined use of MD and XS, together with the external collaboration of an Italian expert in SHP2 biology and a US specialist in XS. Overall, the proposed research will provide a deeper understanding of SHP2 regulation, and dissect the molecular mechanisms implicated in its functional dysregulation in human disease. The planned studies are expected to provide a new class of lead compounds to treat SHP2-associated diseases. Finally, a new computational approach for the design of peptidomimetic inhibitors will be developed.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MARS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MARS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EGeoCC (2019)

Ethnic geography and civil conflict

Read More  

NeuroTick (2019)

The neuroscience of tickling: cerebellar mechanisms and sensory prediction

Read More  

EuroDipl (2020)

European Diplomacy Practices post-Lisbon: Adding Value through Cooperation

Read More